These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3037221)

  • 1. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. II. Binding characteristics in frog brain membranes.
    Simon J; Szücs M; Benyhe S; Tóth G; Hepp J; Borsodi A; Wollemann M; Medzihradszky K
    Life Sci; 1987 Jul; 41(2):185-92. PubMed ID: 3037221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent labeling of opioid receptors with 3H-D-Ala2-Leu5-enkephalin chloromethyl ketone. I. Binding characteristics in rat brain membranes.
    Szücs M; Belcheva M; Simon J; Benyhe S; Tóth G; Hepp J; Wollemann M; Medzihradszky K
    Life Sci; 1987 Jul; 41(2):177-84. PubMed ID: 3037220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mu-receptor specificity of the opioid peptide irreversible reagent, [3H]DALECK.
    Newman EL; Borsodi A; Toth G; Hepp F; Barnard EA
    Neuropeptides; 1986; 8(4):305-15. PubMed ID: 3029618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible labelling of rat brain opioid receptors by enkephalin chloromethyl ketones.
    Benyhe S; Hepp J; Szucs M; Simon J; Borsodi A; Medzihradszky K; Wollemann M
    Neuropeptides; 1986; 8(2):173-81. PubMed ID: 3020473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity labelling of frog brain opioid receptors by dynorphin(1-10) chloromethyl ketone.
    Benyhe S; Ketevan A; Simon J; Hepp J; Medzihradszky K; Borsodi A
    Neuropeptides; 1997 Feb; 31(1):52-9. PubMed ID: 9574838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding characteristics and analgesic activity of D-ALA2-Leu5-enkephalin chloromethyl ketone.
    Szücs M; Benyhe S; Borsodi A; Wollemann M; Jancsó G; Szécsi J; Medzihradszky K
    Life Sci; 1983 Jun; 32(24):2777-84. PubMed ID: 6304443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specificity of the opioid affinity reagent, DALECK, in a set of isolated tissue assay systems.
    Peers E; Shaw JS; Rance MJ; Barnard EA
    Neuropeptides; 1986; 8(4):317-25. PubMed ID: 3029619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A monoclonal antibody recognizing kappa- but not mu- and delta-opioid receptors.
    Maderspach K; Németh K; Simon J; Benyhe S; Szücs M; Wollemann M
    J Neurochem; 1991 Jun; 56(6):1897-904. PubMed ID: 1851205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The occurrence of different kappa opioid receptors (K1 and K2) in frog (Rana esculenta) brain membranes.
    Benyhe S; Varga E; Borsodi A; Wollemann M
    Acta Physiol Hung; 1990; 76(4):291-4. PubMed ID: 1966577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
    Oktem HA; Moitra J; Benyhe S; Toth G; Lajtha A; Borsodi A
    Life Sci; 1991; 48(18):1763-8. PubMed ID: 1850495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E; Giraud P; Audigier Y; Drissi R; Boudouresque F; Conte-Devolx B; Oliver C
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone: a mu specific affinity label for the opioid receptor.
    Benyhe S; Hepp J; Simon J; Borsodi A; Medzihradszky K; Wollemann M
    Neuropeptides; 1987 Apr; 9(3):225-35. PubMed ID: 3037428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of rat brain opioid receptors by [Tyr-3,5-3H]1, D-Ala2, Leu5-enkephalin binding.
    Benyhe S; Tóth G; Kevei J; Szücs M; Borsodi A; Di Gléria K; Szécsi J; Süli-Vargha H; Medzihradszky K
    Neurochem Res; 1985 May; 10(5):627-35. PubMed ID: 2989719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of dermorphin binding to membranes of rat brain and heart.
    Krumins SA
    Neuropeptides; 1987; 9(2):93-102. PubMed ID: 3033543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of kappa 1 and kappa 2 opioid binding sites in frog (Rana esculenta) brain membrane preparation.
    Benyhe S; Varga E; Hepp J; Magyar A; Borsodi A; Wollemann M
    Neurochem Res; 1990 Sep; 15(9):899-904. PubMed ID: 2177154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discrete mapping of brain Mu and delta opioid receptors using selective peptides: quantitative autoradiography, species differences and comparison with kappa receptors.
    Sharif NA; Hughes J
    Peptides; 1989; 10(3):499-522. PubMed ID: 2550910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the interactions of mu and delta selective ligands with [3H]D-Ala2-D-Leu5-enkephalin binding to mouse brain membranes.
    Barrett RW; Vaught JL
    Life Sci; 1983 Dec; 33(24):2439-48. PubMed ID: 6316063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioid receptor labeling with the chloromethyl ketone derivative of (3)H-Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) I: Binding properties of 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl.
    Oktem HA; Varga E; Hepp J; Medzihradzky K; Lajtha A; Borsodi A
    Life Sci; 1991; 48(18):1757-62. PubMed ID: 1850494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of two classes of opioid binding sites in Drosophila melanogaster head membranes.
    Santoro C; Hall LM; Zukin RS
    J Neurochem; 1990 Jan; 54(1):164-70. PubMed ID: 2152792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioid receptors in bovine adrenal medulla.
    Dumont M; Lemaire S
    Can J Physiol Pharmacol; 1984 Oct; 62(10):1284-91. PubMed ID: 6095979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.